REVIEW ARTICLE
Year : 2009 | Volume
: 8 | Issue : 2 | Page : 76--80
The use of magnesium sulphate for the treatment of severe pre-eclampsia and eclampsia
Jamilu Tukur
Department of Obstetrics and Gynaecology, Aminu Kano Teaching Hospital/ Bayero University, Kano, Nigeria
Correspondence Address:
Jamilu Tukur
Department of Obstetrics and Gynaecology, Bayero University, Kano
Nigeria
Background : Pre-eclampsia and eclampsia are important causes of maternal and perinatal morbidity and mortality in the developing countries. There is need to provide the most effective management to pre-eclamptic and eclamptic patients. There is now evidence that magnesium sulphate is the most effective anticonvulsant.
Method : In this article , a literature review was made on the contribution of pre-eclampsia and eclampsia to maternal mortality and how it can be curtailed by the use of magnesium sulphate.
Results : The drug is administered by the Pritchard or Zuspan regimen, although modifications in the two protocols have been reported.
Conclusion : A Nigerian national protocol has been developed on its use. There is need for further training of health workers on how to use this important drug.
How to cite this article:
Tukur J. The use of magnesium sulphate for the treatment of severe pre-eclampsia and eclampsia.Ann Afr Med 2009;8:76-80
|
How to cite this URL:
Tukur J. The use of magnesium sulphate for the treatment of severe pre-eclampsia and eclampsia. Ann Afr Med [serial online] 2009 [cited 2022 Jun 28 ];8:76-80
Available from: https://www.annalsafrmed.org/article.asp?issn=1596-3519;year=2009;volume=8;issue=2;spage=76;epage=80;aulast=Tukur;type=0 |
|
